190 related articles for article (PubMed ID: 17699797)
1. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.
Luangdilok S; Box C; Patterson L; Court W; Harrington K; Pitkin L; Rhŷs-Evans P; O-charoenrat P; Eccles S
Cancer Res; 2007 Aug; 67(16):7907-16. PubMed ID: 17699797
[TBL] [Abstract][Full Text] [Related]
2. Full-length spleen tyrosine kinase inhibits the invasion and metastasis of human laryngeal squamous cell carcinoma.
Li Z; Cai Z; Tao B; Jin Q
Int J Clin Exp Pathol; 2015; 8(12):15786-93. PubMed ID: 26884848
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of full-length spleen tyrosine kinase on invasion and metastasis of human laryngeal squamous cells].
Li Z; Cai Z; Tao B; Jin Q
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Nov; 49(11):943-9. PubMed ID: 25598376
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
5. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.
Ogane S; Onda T; Takano N; Yajima T; Uchiyama T; Shibahara T
Int J Cancer; 2009 Jun; 124(11):2651-7. PubMed ID: 19195024
[TBL] [Abstract][Full Text] [Related]
6. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells.
Agochiya M; Brunton VG; Owens DW; Parkinson EK; Paraskeva C; Keith WN; Frame MC
Oncogene; 1999 Oct; 18(41):5646-53. PubMed ID: 10523844
[TBL] [Abstract][Full Text] [Related]
7. Expression of putative tumor suppressor gene spleen tyrosine kinase in esophageal squamous cell carcinoma.
Dong SW; Zhang P; Zhong RR; Liu Q
Clin Lab; 2013; 59(5-6):647-53. PubMed ID: 23865365
[TBL] [Abstract][Full Text] [Related]
8. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.
Thomas SM; Coppelli FM; Wells A; Gooding WE; Song J; Kassis J; Drenning SD; Grandis JR
Cancer Res; 2003 Sep; 63(17):5629-35. PubMed ID: 14500405
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
[TBL] [Abstract][Full Text] [Related]
11. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
Li J; Sidell N
Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
13. Spleen tyrosine kinase mediates BEAS-2B cell migration and proliferation and human rhinovirus-induced expression of vascular endothelial growth factor and interleukin-8.
Wang X; Mychajlowycz M; Lau C; Gutierrez C; Scott JA; Chow CW
J Pharmacol Exp Ther; 2012 Feb; 340(2):277-85. PubMed ID: 22031919
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of elevated spleen tyrosine kinase expression in nasopharyngeal carcinoma.
Du ZM; Kou CW; Wang HY; Huang MY; Liao DZ; Hu CF; Chen J; Yan LX; Hu LF; Ernberg I; Zeng YX; Shao JY
Head Neck; 2012 Oct; 34(10):1456-64. PubMed ID: 22287277
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated transfer of FRNK augments drug-induced cytotoxicity in cultured SCCHN cells.
Kornberg LJ
Anticancer Res; 2005; 25(6B):4349-56. PubMed ID: 16309239
[TBL] [Abstract][Full Text] [Related]
16. Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck.
Younes MN; Yigitbasi OG; Yazici YD; Jasser SA; Bucana CD; El-Naggar AK; Mills GB; Myers JN
Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):15-23. PubMed ID: 17224516
[TBL] [Abstract][Full Text] [Related]
17. [Functions of spleen tyrosine kinase (Syk) gene and its correlation to neoplasms].
Wang HY; Zhang ZX
Ai Zheng; 2007 May; 26(5):555-60. PubMed ID: 17672952
[TBL] [Abstract][Full Text] [Related]
18. [Regulatory role of Syk gene on vascular endothelial growth factor C expression in breast cancer].
Chen XL; Li L; Zhang YJ
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):805-9. PubMed ID: 22336204
[TBL] [Abstract][Full Text] [Related]
19. Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation.
Wu NL; Huang DY; Wang LF; Kannagi R; Fan YC; Lin WW
J Invest Dermatol; 2016 Jan; 136(1):192-201. PubMed ID: 26763439
[TBL] [Abstract][Full Text] [Related]
20. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells.
Lu J; Lin WH; Chen SY; Longnecker R; Tsai SC; Chen CL; Tsai CH
J Biol Chem; 2006 Mar; 281(13):8806-14. PubMed ID: 16431925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]